Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301Eisaku Miyauchi, Masakazu Ichinose, Taku Nakagawa et al.|The Oncologist|2017Cited by 16
Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M MutationKana Watanabe, Makoto Maemondo, Ryota Saito et al.|Cancers|2023Cited by 9
Randomized phase II trial of uracil/tegafur and cisplatin versus pemetrexed and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-squamous non-small cell lung cancer: NJLCG1001Makoto Maemondo, Kana Watanabe, Yukihiro Toi et al.|Translational Lung Cancer Research|2021Cited by 6
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Nobuhiko Seki, Shigeru Tanzawa et al.|JTO Clinical and Research Reports|2023Cited by 5
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Nobuhiko Seki, Hiroshige Yoshioka et al.|Therapeutic Advances in Medical Oncology|2025Cited by 3